keyword
https://read.qxmd.com/read/38501098/hypoxia-inducible-factor-2%C3%AE-promotes-fibrosis-in-non-alcoholic-fatty-liver-disease-by-enhancing-glutamine-catabolism-and-inhibiting-yes-associated-protein-phosphorylation-in-hepatic-stellate-cells
#21
JOURNAL ARTICLE
Ranran Yan, Hao Cai, Xiaofeng Zhou, Guodan Bao, Zhenzhong Bai, Ri-Li Ge
Non-alcoholic fatty liver disease (NAFLD) has a high global prevalence and affects approximately one-third of adults, owing to high-fat dietary habits and a sedentary lifestyle. The role of hypoxia-inducible factor 2α (HIF-2α) in NAFLD progression remains unknown. This study aimed to investigate the effects of chronic hypoxia on NAFLD progression by examining the role of hypoxia-inducible factor 2α (HIF-2α) activation and that of hepatic stellate cell (HSC)-derived myofibroblasts through glutaminolysis...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38496616/mitochondrial-raf1-regulates-glutamine-catabolism
#22
Ronald L Shanderson, Ian D Ferguson, Zurab Siprashvili, Luca Ducoli, Albert M Li, Weili Miao, Suhas Srinivasan, Mary Grace Velasco, Yang Li, Jiangbin Ye, Paul A Khavari
Raf kinases play vital roles in normal mitogenic signaling and cancer, however, the identities of functionally important Raf-proximal proteins throughout the cell are not fully known. Raf1 proximity proteomics/BioID in Raf1-dependent cancer cells unexpectedly identified Raf1-adjacent proteins known to reside in the mitochondrial matrix. Inner-mitochondrial localization of Raf1 was confirmed by mitochondrial purification and super-resolution microscopy. Inside mitochondria, Raf1 associated with glutaminase (GLS) in diverse human cancers and enabled glutaminolysis, an important source of biosynthetic precursors in cancer...
March 9, 2024: bioRxiv
https://read.qxmd.com/read/38488852/metabolic-reprogramming-of-cancer-cells-by-jmjd6-mediated-pre-mrna-splicing-associated-with-therapeutic-response-to-splicing-inhibitor
#23
JOURNAL ARTICLE
Carolyn M Jablonowski, Waise Quarni, Shivendra Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin, Jie Fang, Ti-Cheng Chang, David Finkelstein, Ji-Hoon Cho, Dongli Hu, Vishwajeeth Pagala, Sadie Miki Sakurada, Shondra M Pruett-Miller, Ruoning Wang, Andrew Murphy, Kevin Freeman, Junmin Peng, Andrew M Davidoff, Gang Wu, Jun Yang
Dysregulated pre-mRNA splicing and metabolism are two hallmarks of MYC-driven cancers. Pharmacological inhibition of both processes has been extensively investigated as potential therapeutic avenues in preclinical and clinical studies. However, how pre-mRNA splicing and metabolism are orchestrated in response to oncogenic stress and therapies is poorly understood. Here, we demonstrate that jumonji domain containing 6, arginine demethylase, and lysine hydroxylase, JMJD6, acts as a hub connecting splicing and metabolism in MYC-driven human neuroblastoma...
March 15, 2024: ELife
https://read.qxmd.com/read/38467390/in-vitro-and-in-silico-analysis-unravelled-clinically-desirable-attributes-of-bacillus-altitudinis-l-asparaginase
#24
JOURNAL ARTICLE
V P Lailaja, Vishnu Hari, T G Sumithra, V N Anusree, Gayathri Suresh, N K Sanil, S R Krupesha Sharma, A Gopalakrishnan
AIMS: To identify a marine L-asparaginase with clinically desirable attributes and characterize the shortlisted candidate through in silico tools. METHODS AND RESULTS: Marine bacterial strains (number=105) isolated from marine crabs were evaluated through a stepwise strategy incorporating the crucial attributes for therapeutic safety. The results demonstrated the potential of eight bacterial species for extracellular L-asparaginase production. However, only one isolate (B...
March 11, 2024: Journal of Applied Microbiology
https://read.qxmd.com/read/38466743/hepatitis-b-virus-e-antigen-induces-atypical-metabolism-and-differentially-regulates-programmed-cell-deaths-of-macrophages
#25
JOURNAL ARTICLE
Yumei Li, Christine Wu, Jiyoung Lee, Qiqi Ning, Juhyeon Lim, Hyungjin Eoh, Sean Wang, Benjamin P Hurrell, Omid Akbari, Jing-Hsiung James Ou
Macrophages can undergo M1-like proinflammatory polarization with low oxidative phosphorylation (OXPHOS) and high glycolytic activities or M2-like anti-inflammatory polarization with the opposite metabolic activities. Here we show that M1-like macrophages induced by hepatitis B virus (HBV) display high OXPHOS and low glycolytic activities. This atypical metabolism induced by HBV attenuates the antiviral response of M1-like macrophages and is mediated by HBV e antigen (HBeAg), which induces death receptor 5 (DR5) via toll-like receptor 4 (TLR4) to induce death-associated protein 3 (DAP3)...
March 11, 2024: PLoS Pathogens
https://read.qxmd.com/read/38462444/changes-in-the-glutamate-gaba-system-in-the-hippocampus-of-rats-with-age-and-during-alzheimer-s-disease-signs-development
#26
JOURNAL ARTICLE
Alena O Burnyasheva, Natalia A Stefanova, Nataliya G Kolosova, Darya V Telegina
GABA and glutamate are the most abundant neurotransmitters in the CNS and play a pivotal part in synaptic stability/plasticity. Glutamate and GABA homeostasis is important for healthy aging and reducing the risk of various neurological diseases, while long-term imbalance can contribute to the development of neurodegenerative disorders, including Alzheimer's disease (AD). Normalization of the homeostasis has been discussed as a promising strategy for prevention and/or treatment of AD, however, data on the changes in the GABAergic and glutamatergic systems with age, as well as on the dynamics of AD development, are limited...
December 2023: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38458203/aging-induced-trna-glu-derived-fragment-impairs-glutamate-biosynthesis-by-targeting-mitochondrial-translation-dependent-cristae-organization
#27
JOURNAL ARTICLE
Dingfeng Li, Xinyi Gao, Xiaolin Ma, Ming Wang, Chuandong Cheng, Tian Xue, Feng Gao, Yong Shen, Juan Zhang, Qiang Liu
Mitochondrial cristae, infoldings of the mitochondrial inner membrane, undergo aberrant changes in their architecture with age. However, the underlying molecular mechanisms and their contribution to brain aging are largely elusive. Here, we observe an age-dependent accumulation of Glu-5'tsRNA-CTC, a transfer-RNA-derived small RNA (tsRNA), derived from nuclear-encoded tRNAGlu in the mitochondria of glutaminergic neurons. Mitochondrial Glu-5'tsRNA-CTC disrupts the binding of mt-tRNALeu and leucyl-tRNA synthetase2 (LaRs2), impairing mt-tRNALeu aminoacylation and mitochondria-encoded protein translation...
March 1, 2024: Cell Metabolism
https://read.qxmd.com/read/38450598/deficiency-in-slc25a15-a-hypoxia-responsive-gene-promotes-hepatocellular-carcinoma-by-reprogramming-glutamine-metabolism
#28
JOURNAL ARTICLE
Qiangnu Zhang, Teng Wei, Wen Jin, Lesen Yan, Lulin Shi, Siqi Zhu, Yu Bai, Yuandi Zeng, Zexin Yin, Jilin Yang, Wenjian Zhang, Meilong Wu, Yusen Zhang, Gongze Peng, Stephanie Roessler, Liping Liu
BACKGROUND & AIMS: The role of solute carrier family 25 member 15 (SLC25A15), a critical component of the urea cycle, in hepatocellular carcinoma (HCC) progression remains poorly understood. This study investigated the impact of SLC25A15 on HCC progression and its mechanisms. METHODS: We systematically investigated the function of SLC25A15 in HCC progression using large-scale data mining and cell, animal, and organoid models. Furthermore, we analyzed its involvement in reprogramming glutamine metabolism...
February 2024: Journal of Hepatology
https://read.qxmd.com/read/38438397/filament-formation-drives-catalysis-by-glutaminase-enzymes-important-in-cancer-progression
#29
JOURNAL ARTICLE
Shi Feng, Cody Aplin, Thuy-Tien T Nguyen, Shawn K Milano, Richard A Cerione
The glutaminase enzymes GAC and GLS2 catalyze the hydrolysis of glutamine to glutamate, satisfying the 'glutamine addiction' of cancer cells. They are the targets of anti-cancer drugs; however, their mechanisms of activation and catalytic activity have been unclear. Here we demonstrate that the ability of GAC and GLS2 to form filaments is directly coupled to their catalytic activity and present their cryo-EM structures which provide a view of the conformational states essential for catalysis. Filament formation guides an 'activation loop' to assume a specific conformation that works together with a 'lid' to close over the active site and position glutamine for nucleophilic attack by an essential serine...
March 4, 2024: Nature Communications
https://read.qxmd.com/read/38432394/baicalein-is-a-potential-agent-targeting-glutamine-that-induces-apoptosis-by-inhibiting-the-glutamine-mtor-metabolic-pathway-in-lung-cancer
#30
JOURNAL ARTICLE
Jingyang Li, Di Zhang, Shaohui Wang, Peng Yu, Jiayi Sun, Yi Zhang, Xianli Meng, Juan Li, Li Xiang
INTRODUCTION: Baicalein, a bioactive component of Scutellaria baicalensis Georgi, has been shown to promote apoptosis in non-small cell lung cancer cells. However, previous studies have not determined if baicalein exerts proapoptotic effects by modulating the metabolic pathways. OBJECTIVE: To investigate if baicalein induces apoptosis in lung cancer cells by modulating the glutamine-mTOR metabolic pathway. METHODS: The in vivo anti-lung cancer activity of baicalein (50, 100, and 200 mg/kg) was evaluated using a xenograft model...
March 1, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38432356/repeated-antibiotic-drug-treatment-negatively-affects-memory-function-and-glutamatergic-nervous-system-of-the-hippocampus-in-mice
#31
JOURNAL ARTICLE
Kohei Takahashi, Kazuhiro Kurokawa, Kazuya Miyagawa, Atsumi Mochida-Saito, Hiroshi Takeda, Minoru Tsuji
The gut microbiota is associated with memory; however, the relationship between dysbiosis-induced memory deficits and hippocampal glutamatergic neurons remains unclear. In our study, a mouse dysbiosis model showed impaired memory-related behavior in the passive avoidance test; decreased expression levels of glutaminase, excitatory amino acid transporter (EAAT)1, EAAT2, vesicular glutamate transporter 2, synaptophysin, brain-derived neurotrophic factor, doublecortin, neuronal nuclear protein, glial fibrillary acidic protein, and S100β; and decreased phosphorylation of N-methyl-D-aspartate receptor subunit 1, calmodulin-dependent protein kinase II, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit 1, and cAMP response element-binding protein in the hippocampus...
March 1, 2024: Neuroscience Letters
https://read.qxmd.com/read/38426501/nets-unleashed-neutrophil-extracellular-traps-boost-chemotherapy-against-colorectal-cancer
#32
JOURNAL ARTICLE
Alexandra Mousset, Jean Albrengues
Chemotherapy, which primarily acts on cancer cells, can influence the tumor microenvironment and the recruitment and behavior of stromal cells. In this issue of the JCI, Li et al. explored the potent anticancer effect of the combination of a glutaminase inhibitor (CB-839) and 5-FU against PIK3CA-mutant colorectal cancer tumors. This chemotherapy treatment strongly induced the recruitment of neutrophils that formed neutrophil extracellular traps in cancer, which actively killed cancer cells by inducing apoptosis...
March 1, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38412663/preclinical-evaluation-of-engineered-l-asparaginase-variants-to-improve-the-treatment-of-acute-lymphoblastic-leukemia
#33
JOURNAL ARTICLE
Soumika Sengupta, Mainak Biswas, Khushboo A Gandhi, Saurabh Kumar Gupta, Poonam B Gera, Vikram Gota, Avinash Sonawane
INTRODUCTION: Escherichia coli l-asparaginase (EcA), an integral part of multi-agent chemotherapy protocols of acute lymphoblastic leukemia (ALL), is constrained by safety concerns and the development of anti-asparaginase antibodies. Novel variants with better pharmacological properties are desirable. METHODS: Thousands of novel EcA variants were constructed using protein engineering approach. After preliminary screening, two mutants, KHY-17 and KHYW-17 were selected for further development...
February 26, 2024: Translational Oncology
https://read.qxmd.com/read/38405110/safety-evaluation-of-the-food-enzyme-glutaminase-from-the-non-genetically-modified-bacillus-amyloliquefaciens-strain-ae-gt
#34
JOURNAL ARTICLE
Vittorio Silano, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Claude Lambré, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger-Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis, Holger Zorn, Magdalena Andryszkiewicz, Daniele Cavanna, Yi Liu, Simone Lunardi, Elsa Nielsen, Karin Norby, Giulio di Piazza, Yrjö Roos, Andrew Chesson
The food enzyme glutaminase (l-glutamine amidohydrolase; EC 3.5.1.2) is produced with the non-genetically modified Bacillus amyloliquefaciens strain AE-GT by Amano Enzyme Inc. The production strain met the requirements for the qualified presumption of safety (QPS) approach. The food enzyme is intended to be used in five food manufacturing processes. Dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.462 mg TOS/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of concerns resulting from the food enzyme's manufacturing process, toxicity tests were considered unnecessary by the Panel...
February 2024: EFSA journal
https://read.qxmd.com/read/38403216/homology-modeling-and-molecular-docking-studies-to-decrease-glutamine-affinity-of-yarrowia-lipolytica-l-asparaginase
#35
JOURNAL ARTICLE
Farshad Darvishi, Elham Beiranvand, Hourieh Kalhor, Behzad Shahbazi, Ladan Mafakher
L-Asparaginase is a key component in the treatment of leukemias and lymphomas. However, the glutamine affinity of this therapeutic enzyme is an off-target activity that causes several side effects. The modeling and molecular docking study of Yarrowia lipolytica L-asparaginase (YL-ASNase) to reduce its l-glutamine affinity and increase its stability was the aim of this study. Protein-ligand interactions of wild-type and different mutants of YL-ASNase against L-asparagine compared to l-glutamine were assessed using AutoDock Vina tools because the crystal structure of YL-ASNase does not exist in the protein data banks...
February 23, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38386265/targeting-glutamine-metabolism-exhibits-anti-tumor-effects-in-thyroid-cancer
#36
JOURNAL ARTICLE
G-Q Zhang, C Xi, N-T Ju, C-T Shen, Z-L Qiu, H-J Song, Q-Y Luo
BACKGROUND: Effective treatment for patients with advanced thyroid cancer is lacking. Metabolism reprogramming is required for cancer to undergo oncogenic transformation and rapid tumorigenic growth. Glutamine is frequently used by cancer cells for active bioenergetic and biosynthetic needs. This study aims to investigate whether targeting glutamine metabolism is a promising therapeutic strategy for thyroid cancer. METHODS: The expression of glutaminase (GLS) and glutamate dehydrogenase (GDH) in thyroid cancer tissues was evaluated by immunohistochemistry, and glutamine metabolism-related genes were assessed using real time-qPCR and western blotting...
February 22, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38377021/inhibiting-glutaminase-exerts-opposite-effects-on-ovariectomy-induced-and-age-related-reductions-in-murine-bone-mass
#37
JOURNAL ARTICLE
Qian Guo, Hongjian Zhao, Zijian Dong, Haozhe Cheng, Meipeng Zhu, Zhong Fang
Recent studies have provided links between glutamine metabolism and bone remodeling, but little is known about its role in primary osteoporosis progression. We aimed to determine the effects of inhibiting glutaminase (GLS) on two types of primary osteoporosis and elucidate the related metabolism. To address this issue, age-related and ovariectomy (OVX)-induced bone loss mouse models were used to study the in vivo effects of CB-839, a potent and selective GLS inhibitor, on bone mass and bone turnover. We also studied the metabolic profile changes related with aging and GLS inhibition in primary bone marrow stromal cells (BMSC) and that related with OVX and GLS inhibition in primary bone marrow-derived monocytes (BMM)...
February 6, 2024: Aging and Disease
https://read.qxmd.com/read/38372449/lrpprc-promotes-glycolysis-by-stabilising-ldha-mrna-and-its-knockdown-plus-glutamine-inhibitor-induces-synthetic-lethality-via-m-6-a-modification-in-triple-negative-breast-cancer
#38
JOURNAL ARTICLE
Yuanhang Yu, Huifang Deng, Wenwen Wang, Shihan Xiao, Renjing Zheng, Lianqiu Lv, Han Wang, Jianying Chen, Bo Zhang
BACKGROUND: Targeted therapy for triple-negative breast cancer (TNBC) remains a challenge. N6-methyladenosine (m6 A) is the most abundant internal mRNA modification in eukaryotes, and it regulates the homeostasis and function of modified RNA transcripts in cancer. However, the role of leucine-rich pentatricopeptide repeat containing protein (LRPPRC) as an m6 A reader in TNBC remains poorly understood. METHODS: Western blotting, reverse transcription-polymerase chain reaction (RT-qPCR) and immunohistochemistry were used to investigate LRPPRC expression levels...
February 2024: Clinical and Translational Medicine
https://read.qxmd.com/read/38366114/the-glutamatergic-system-in-alzheimer-s-disease-a-systematic-review-with-meta-analysis
#39
Carolina Soares, Lucas Uglione Da Ros, Luiza Santos Machado, Andreia Rocha, Gabriela Lazzarotto, Giovanna Carello-Collar, Marco A De Bastiani, João Pedro Ferrari-Souza, Firoza Z Lussier, Diogo O Souza, Pedro Rosa-Neto, Tharick A Pascoal, Bruna Bellaver, Eduardo R Zimmer
Glutamatergic neurotransmission system dysregulation may play an important role in the pathophysiology of Alzheimer's disease (AD). However, reported results on glutamatergic components across brain regions are contradictory. Here, we conducted a systematic review with meta-analysis to examine whether there are consistent glutamatergic abnormalities in the human AD brain. We searched PubMed and Web of Science (database origin-October 2023) reports evaluating glutamate, glutamine, glutaminase, glutamine synthetase, glutamate reuptake, aspartate, excitatory amino acid transporters, vesicular glutamate transporters, glycine, D-serine, metabotropic and ionotropic glutamate receptors in the AD human brain (PROSPERO #CDRD42022299518)...
February 16, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38365969/set7-9-aggravates-ischemic-brain-injury-via-enhancing-glutamine-metabolism-in-a-blocking-sirt5-manner
#40
JOURNAL ARTICLE
Jinghuan Wang, Subei Tan, Yuyu Zhang, Jie Xu, Yuhui Li, Qianwen Cheng, Chen Ding, Xinhua Liu, Jun Chang
The aberrant expression of methyltransferase Set7/9 plays a role in various diseases. However, the contribution of Set7/9 in ischemic stroke remains unclear. Here, we show ischemic injury results in a rapid elevation of Set7/9, which is accompanied by the downregulation of Sirt5, a deacetylase reported to protect against injury. Proteomic analysis identifies the decrease of chromobox homolog 1 (Cbx1) in knockdown Set7/9 neurons. Mechanistically, Set7/9 promotes the binding of Cbx1 to H3K9me2/3 and forms a transcription repressor complex at the Sirt5 promoter, ultimately repressing Sirt5 transcription...
February 16, 2024: Cell Death and Differentiation
keyword
keyword
103064
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.